ArticleThoracic cancer2025

NAT10 Knockdown Improves Cisplatin Sensitivity in Non-Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway.

Qi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.